Table 4.
Ranking
|
Ref.
|
Title
|
Source title
|
Cited by
|
Impact index per article1
|
1st | Xiao et al[58], 2020 | “Evidence for Gastrointestinal Infection of SARS-CoV-2” | Gastroenterology | 798 | 617.5 |
2nd | Xu et al[59], 2020 | “Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding” | Nature Medicine | 525 | 384.0 |
3rd | Gu et al[52], 2020 | “COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission” | Gastroenterology | 507 | 342.5 |
4th | Pan et al[55], 2020 | “Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study” | American Journal of Gastroenterology | 464 | 352.5 |
5th | Wu et al[57], 2020 | “Prolonged presence of SARS-CoV-2 viral RNA in faecal samples” | Lancet Gastroenterology and Hepatology | 451 | 374.5 |
6th | Jin et al[53], 2020 | “Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms” | Gut | 362 | 277.0 |
7th | Cheung et al[10], 2020 | “Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis” | Gastroenterology | 356 | 269.5 |
8th | Lamers et al[54], 2020 | “SARS-CoV-2 productively infects human gut enterocytes” | Science | 338 | 317.5 |
9th | Yeo et al[60], 2020 | “Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?” | Lancet Gastroenterology and Hepatology | 323 | 202.0 |
10th | Tian et al[56], 2020 | “Gastrointestinal features in COVID-19 and the possibility of faecal transmission” | Alimentary Pharmacology and Therapeutics | 269 | 189.0 |
The impact index per article is presented based on Reference Citation Analysis [source: Baishideng Publishing Group Inc. (Pleasanton, CA 94566, United States)].